Educating Young People With Diabetes - World Diabetes Day 14 November

Educating Young People With Diabetes - World Diabetes Day 14 November
World Diabetes Day is on 14 November this year highlighting that diabetes is on the increase and to create awareness and help reduce figures from growing larger.

New Drug Class To Combat Alzheimer's Being Developed By UIC Researchers
The University of Illinois at Chicago College of Pharmacy has received a four-year, $1.87 million grant from the National Institutes of Health to continue research into discovering a new drug class that will treat Alzheimer's disease.

Cohort Study Funded By Helmholtz
The Helmholtz Association will invest around 20 million euros over the next five years to put together a large-scale, long-term cohort study. The goal of the study will be to illuminate the causes of common health problems like cardiovascular disease, cancer, diabetes and dementia, as well as to identify risk factors and effective methods of prevention. The Helmholtz Association's Senate reached the decision yesterday, 22nd October.

Unwrapping The Elements Of Life
Researchers at Newcastle University have taken a step forward in our understanding of how the fundamental building blocks of life are put together. In a paper published in Nature, the team led by Professor Nigel Robinson have revealed a mechanism that ensures the right metal goes to the right protein. Proteins are essential and involved in just about every process in living cells. Life, microbe, plant or human, is a painstaking assembly of trillions of atoms.

Foot Pain? You May Have Diabetes
Do you ever feel burning, tingling or numbness in your feet and toes? The American College of Foot and Ankle Surgeons (ACFAS) warns against ignoring these symptoms. They could be a warning sign of diabetes. Foot and ankle surgeons say those symptoms may be caused by a condition called diabetic peripheral neuropathy, or nerve damage.

Persistent Vaccination Effect Of GRAZAX(R) After Completion Of Treatment
Breakthrough: Results from the fourth year in a long-term clinical study prove the disease modifying effect of GRAZAX(R). For the first time ever, it is documented that the positive clinical effect of the tablet vaccine persists after completion of treatment. Today, ALK announces main results from the first follow-up year in a long-term study (GT-08) with GRAZAX(R), the company's tablet-based vaccine against grass pollen allergy.